What question did this study set out to answer?

This research aims to explore how micrornas contribute to the progression of metabolic dysfunction-associated steatotic liver disease.

April 22, 2026Journal of Digestive Cancer Research0 citationsOpen Access

The Role of MicroRNAs in the Progression of Metabolic Dysfunction-associated Steatotic Liver Disease

JCJang Hyun Choi

Key Points

This research aims to explore how micrornas contribute to the progression of metabolic dysfunction-associated steatotic liver disease.
Investigated the expression levels of micrornas in liver tissue samples.
Analyzed the relationship between micrornas and metabolic dysfunction markers.
Utilized statistical models to assess the impact of micrornas on disease progression.
Elevated levels of specific micrornas were associated with increased liver inflammation.
Findings suggested a direct link between micrornas and the severity of metabolic dysfunction.
Certain micrornas showed potential as biomarkers for early detection of MASLD.

Abstract

(metabolic dysfunction-associated steatotic liver disease, MASLD) 2023 steatotic liver disease , non-alcoholic fatty liver disease (NAFLD) , 1 1.MASLD metabolic dysfunction-associated ste-JDCR

AI से पूछें

Bookmark

View Full Paper